Our primary comparison between Tirzepatide and Semaglutide yielded 25,060 matched pairs, while other treatment comparisons produced cohorts of varying sizes, from 7240 pairs for Tirzepatide versus Naltrexone/Bupropion to 18,892 pairs for Tirzepatide versus Phentermine (Fig
Epithalon Laboratory and Human-Cell Research Cell experiments generate hypotheses but do not establish clinical anti-ageing effects
#cancer #research To view or add a comment, sign in This new editorial in Supportive Care in Cancer by Siobhn Gaynor, patient advocate, and Professor Seamus OReilly, Clinical Lead at Cancer Trials Ireland, with co-author Dr Erica Mayer, calls for a stronger focus on quality of life and the patient perspective when assessing cancer therapies
Second, propranolol can make exercise feel harder, particularly during the first few weeks of treatment or after a dose increase
Regular monitoring becomes even more important when combining these treatments